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Running title: Low levels of superoxide in macrophages following skeletal muscle 
injury 
 
Key words: oxidative stress, tissue repair, sterile inflammation. 
 
Highlights: 
- Macrophage-derived ROS release is absent or weak after an acute skeletal 
muscle injury. 
- Antioxidant gene expression is similar in pro and anti-inflammatory macrophages. 
- Antioxidant supplementation is deleterious for skeletal muscle regeneration after 
an acute injury. 
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ABSTRACT 
Macrophages are key players of immunity that display different functions according to 
their activation states. In a regenerative context, pro-inflammatory macrophages 
(Ly6Cpos) are involved in the mounting of the inflammatory response whereas anti-
inflammatory macrophages (Ly6Cneg) dampen the inflammation and promote tissue 
repair. Reactive oxygen species (ROS) production is a hallmark of tissue injury and 
of subsequent inflammation as described in a bacterial challenge context. However, 
whether macrophages produce ROS following a sterile tissue injury is uncertain. In 
this study, we used complementary in vitro, ex vivo and in vivo experiments in mouse 
to show that macrophages do not release ROS following a sterile injury in skeletal 
muscle. Furthermore, expression profiles of genes involved in the response to 
oxidative stress in Ly6Cpos and Ly6Cneg macrophage subsets did not indicate any 
antioxidant response in this context. Finally, in vivo, pharmacological antioxidant 
supplementation with N-Acetyl-cysteine (NAC) following skeletal muscle injury did not 
alter macrophage phenotype during skeletal muscle regeneration. Overall, these 
results indicate that following a sterile injury, macrophage-derived ROS release is not 
involved in the regulation of the inflammatory response in the regenerating skeletal 
muscle. 
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INTRODUCTION 
Macrophages play various important roles in tissue homeostasis (Chazaud, 2014). 
They exhibit a wide spectrum of phenotypes or inflammatory status, which are 
associated with a diversity of functions (Chazaud, 2014). Upon an immune challenge, 
macrophages invading the infected area exhibit a pro-inflammatory phenotype, that 
support microbicidal activity, mainly through the activation of Toll-like receptors 
(TLRs) upon recognition of Pathogen Associated Molecular Patterns (PAMPs). Once 
the pathogens phagocytozed and inactivated, resolution of inflammation takes place 
to avoid too much tissue degradation (Chazaud, 2014). Inflammation is often 
associated with an increase of the production of reactive oxygen species (ROS) (Le 
Moal et al., 2017). It is largely accepted that macrophages produce and release ROS 
to support bactericidal activity and counteract with invader pathogens (West et al., 
2011). Thus, ROS are important mediators of macrophage functions during immune 
challenges (Brune et al., 2013; Forman and Torres, 2001). 
After a tissue damage that does not involve bacteria or virus (i.e. sterile 
inflammation), the activation of macrophages infiltrating the injured area was 
evidenced via the Damage Associated Molecular Patterns (DAMPs) that also activate 
TLRs. However, the extent and quality of the pro-inflammatory status of these pro-
inflammatory macrophages have been poorly addressed in vivo. In this context, we 
recently showed that soon after skeletal muscle injury, monocyte-derived 
macrophages exhibit a pro-inflammatory status, which is different from that of 
classical M1 (IFN driven) activation and is likely related to tissue damage (Varga et 
al., 2016). Few days after the injury, the resolution of inflammation takes place and 
macrophages switch their phenotype towards an anti-inflammatory/recovery status to 
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exert repairing function in the tissue (Arnold et al., 2007; Mounier et al., 2013; 
Perdiguero et al., 2011; Varga et al., 2013) . 
Whether pro-oxidant characteristics of macrophages that were described in the 
context of immune challenge does occur in the context of sterile inflammation is still 
uncertain. iNOS, which participates in the formation of Reactive Nitrogen Species 
(RNS) and ROS, is expressed by inflammatory macrophages during the first days of 
muscle regeneration, then its expression declines with time, notably when 
macrophages acquire the recovery inflammatory status (Mounier et al., 2013). Mice 
deficient for inos fail to regenerate correctly because of a defect of myogenesis 
(Rigamonti et al., 2013) suggesting, because inos is mainly expressed by 
inflammatory macrophages infiltrating the injured area, that macrophage-derived 
iNOS plays a role in skeletal muscle regeneration. However, despite the assumption 
that inflammatory macrophages generally produce ROS that are detrimental for the 
tissue, no study has characterized macrophage ROS production in the context of 
skeletal muscle regeneration or tissue repair. 
The aim of the present study was to evaluate the production of ROS by macrophage 
populations during skeletal muscle regeneration. To address this question, we 
combined in vitro and ex vivo approaches of direct biochemical measurements of 
ROS entities, ex vivo analysis of the "oxidative" gene profile of macrophages isolated 
from regenerating muscle, and in vivo pharmacological antioxidant supplementation 
during skeletal muscle regeneration.  
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MATERIALS AND METHODS 
Macrophage culture 
Macrophages were obtained from bone marrow (BM) precursor cells as previously 
described (Mounier et al., 2013). Briefly, total BM was cultured in DMEM (Gibco) 
containing 20% fetal bovine serum (FBS) and 30% conditioned medium of L929 cell 
line. Macrophages were seeded (200 000 cells/cm2) and activated in DMEM medium 
containing 10% FBS for 3 days as follows: IFN- (50 ng/ml), IL-4 (10 ng/ml), IL-10 (10 
ng/ml), Muscle Damage Associated Molecular Patterns (DAMPS) (homogenate from 
a muscle injured by ischemia/reperfusion, 1 g/ml), lipopolysaccharide (LPS, 10 
ng/ml) and Phorbol 12-myristate 13 acetate (PMA, 50 ng/ml). After several washes, 
conditioned medium was obtained after 24h of culture of activated macrophages in 
DMEM serum-free medium. 
Superoxide ion production assessment 
Superoxide ion production assessment procedure was previously fully detailed 
(Bernard et al., 2012). Ferricytochrome c reduction was used to assess the 
superoxide ion production by macrophages. Macrophages activated as described 
above were incubated at 37°C for 2 h with 1 ml of HEPES buffer (53 mM HEPES) pH 
7.4 containing 14.6 mM glucose, 358 mM NaCl, 12.7 mM KCl, 3.1 mM KH2PO4, 6.1 
mM MgSO4, 3.1 mM CaCl2, 13 mM NaHCO3, 0.4 mM EDTA and 100 µM 
ferricytochrome. Absorbance was read at 550 nm with a spectrophotometer 
(BioSpectrometer Basic Eppendorf). Contribution of ferricytochrome c at 100 μM 
(absorbance at 800 nm) was substracted. Similar measurements were realized on 
macrophages isolated by FACs (see below) and subsequently plated for 2 h in the 
absence or presence of PMA (50 ng/ml) to induce an oxidative burst (Abbas et al., 
2014). 
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Superoxide dismutase expression 
Protein concentration was determined in macrophage lysates using BCA protein 
assay (Uptima-Interchim). Western blot analysis was performed to examine the 
expression of MnSOD (rabbit polyclonal anti-human SOD2 200 µg/ml, Santa Cruz 
Biotechnology) and Cu-ZnSOD (rabbit polyclonal anti-human SOD1 200 µg/ml, Santa 
Cruz Biotechnology) versus that of actin (Goat polyclonal anti-human actin 200 
µg/ml, Santa Cruz Biotechnology). Quantification of the band intensity was performed 
using ImageJ Software. 
Macrophage H2O2 release 
Extracellular H2O2 was detected using the Amplex Red hydrogen 
peroxide/peroxidase assay kit (Invitrogen). Macrophage-conditioned medium was 
collected and incubated with the Amplex Red reagent (50 μl of 10 mM solution) and 
horseradish peroxidase (100 μl of 10 U/ml solution) in 0.25 M sodium phosphate 
buffer for 30 min. Absorbance intensity was measured on an Apollo LB 911 plate 
reader (Berthold Technologies) at 560 nm.  
Skeletal muscle injury 
Eight week-old C57/Bl6 and CX3CR1GFP/+ male mice were used for N-acetylcysteine 
(NAC, Sigma) supplementation protocol and extraction of macrophages from 
regenerating muscle, respectively. Mice were bred and used in compliance with 
French and European regulations. Principal investigators are licensed for animal 
experimentation and the ethical committee validated the protocol. Muscle injury was 
caused by injection of cardiotoxin (CTX) in the Tibialis Anterior muscle as previously 
described (Mounier et al., 2013). In some experiments, LPS (50 μg/ml final) was co-
injected with CTX as previously described (Varga et al., 2016). In some experiments, 
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NAC was administered at 4% in drinking water for 8 days from the day of injury, as 
previously described (Terrill et al., 2012). 
Isolation of immune cells from regenerating muscle 
Immune cells were isolated as described previously (Mounier et al., 2013; Varga et 
al., 2016). Briefly, muscles were minced and digested with collagenase B 0.2%. 
CD45+ cells were isolated by magnetic sorting procedure (Miltenyi Biotec) and further 
labeled with APC-CD64 and PE-Ly6C antibodies for C57/Bl6 mice and with an APC- 
Ly6C (all from eBiosciences) antibody for CX3CR1GFP/+ mice. Cells were sorted using 
a FACS Aria II cell sorter (BD Biosciences). 
Histological analysis 
At different time-points after injury (day 4, 8 and 28) regenerating muscles were 
harvested, snap-frozen in nitrogen-chilled isopentane and kept at -80°C until 
analysis. 10 m-thick muscle cryosections were prepared and used for H/E staining 
and immunofluorescent staining. Cryosections were treated with antibodies directed 
against F4/80 (#ab6640, Abcam), iNOS (#ab15323, Abcam), and CD206 (#sc-58987, 
Santa Cruz) revealed with FITC-or Cy3-conjugated antibodies (Jackson 
Immunoresearch Inc). Pictures were recorded with Axioscop microscope (Zeiss) at 
20X of magnification connected to AxioCam ICc5 (Zeiss). For each condition in each 
experiment, at least 8-10 randomly chosen fields were counted. The number of 
labeled macrophages was calculated using ImageJ software and was expressed as a 
percentage of total macrophages. 
For Cross Section Area (CSA) analysis, cryosections were labeled with antibodies 
directed against Laminin (#L9393, Sigma-Aldrich) and revealed with FITC-conjugated 
secondary antibody. Pictures covering the whole cryosection were recorded with an 
Axio Observer.Z1 (Zeiss) at 10X of magnification connected to a CoolSNAP HQ2 
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CCD Camera (Photometrics). CSA was determined manually using ImageJ software. 
A mean of 2345 +/- 542 fibers were analyzed per TA muscle. 
For satellite cells analysis, fresh cryosections were labeled with antibodies directed 
against Pax7 (clone 4ea, DHSB) and Laminin (#L9393, Sigma-Aldrich) revealed with 
Cy3- and FITC-conjugated antibodies, respectively. Pictures were recorded with an 
Axio Imager.Z1 (Zeiss) at 20X of magnification connected to a CoolSNAP Myo CCD 
Camera (Photometrics). For each condition, 10 randomly chosen fields were 
counted. The number of satellite cells was determined manually using ImageJ 
software and expressed as the number of Pax7+ cells per 100 fibers. 
Statistical analyses 
Results are expressed as means ± SEM. All experiments were carried out with at 
least 3 different primary cultures or 3 mice for in vivo analyses. Isolation of 
macrophages from regenerating muscle required 3 to 5 mice that were pooled. 
Mann- Whitney and Kruskal-Wallis tests were done with Prism software.  
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RESULTS 
Pro- and anti-inflammatory macrophages release similar levels of ROS in vitro 
To investigate ROS production by differentially activated macrophages, BM-derived 
macrophages were treated with a (IFN-), with IL-4 or with IL-10 to trigger pro-
inflammatory, alternative and anti-inflammatory activation, respectively (Murray et al., 
2014). Superoxide production in conditioned medium was assessed using 
ferricytochrome c reduction assay (Bernard et al., 2012). This method, based on the 
reduction of cytochrome c by superoxide to form detectable ferrocytochrome, reflects 
the extracellular production of superoxide. No significative superoxide production was 
observed upon the 3 treatments, despite a slight increase by macrophages activated 
with IFN (Figure 1A). To investigate ROS production by pro-inflammatory 
macrophages in vitro, cells were treated with various effectors known to induce pro-
inflammatory states including a ROS-inducer (PMA), a bacterial mimetic (LPS) and a 
lysate from injured skeletal muscle (DAMPS). Because the measurement of anion 
superoxide release has never been performed in these conditions, we added two 
positive controls known as superoxide generators: a strong chemical inducer (PMA) 
(Nathan and Root, 1977) and LPS. LPS activates superoxide production and 
hydrogen peroxide-derived superoxide. We also tested DAMPS as a putative 
superoxide activator. Hence, we validated our measurement setup and were able to 
underline the differences between classical models of activation based on cytokine 
treatment and the above-mentioned treatments. Among the 3 treatments, only PMA 
(+139±9%) (p<0.05) treatment induced superoxide detection as compared with 
untreated macrophages (NT) (Figure 1A). To further explore ROS metabolism in 
activated macrophages, the level of H2O2, which is the product of superoxide 
dismutation by superoxide dismutases (SODs) (Holmstrom and Finkel, 2014), was 
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measured in conditioned media. Surprisingly, hydrogen peroxide production was 
similar in all macrophage populations (Figure 1B). The important lability of H2O2 can 
explain these results. Overall, these data indicate that macrophages released similar 
levels of superoxide and H2O2 irrespective of their activation state. 
We further examined the expression of superoxide dismutase (SOD) enzymes by 
activated macrophages. MnSOD (or SOD2) is a mitochondrial enzyme responsible of 
the dismutation of primary formed superoxide into hydrogen peroxide, the most 
common reaction of ROS metabolism cascade (Holmstrom and Finkel, 2014). 
MnSOD expression was higher in IFN macrophages as compared with (IL-10) 
macrophages (p<0.05) (Figure 1C). Additionally, cytosolic SOD1 (or CuZn-SOD) 
expression was not significantly different in the various activated macrophages 
(Figure 1D). These data indicate that mitochondrial SOD2 was overexpressed only 
in pro-inflammatory macrophages, leading to an improvement of the dismutation 
capacity of pro-inflammatory macrophages that may result in a similar ROS release 
as compared with other activated macrophages. 
 
Macrophages produce low levels of superoxide during post-injury skeletal 
muscle regeneration in vivo 
To investigate ROS production by macrophages during muscle regeneration, 
macrophages subsets and neutrophils were sorted from regenerating muscle at day 2 
after injury and assayed for the evaluation of superoxide production (Figure 2A). At 
day 2, both LyC6pos and Ly6Cneg populations are equally present (Mounier et al., 
2013; Varga et al., 2013). No significant superoxide production was detected in both 
Ly6Cpos and Ly6Cneg macrophage subsets and neutrophils, as compared with the 
control solution (Figure 2A, right panel). To test the experimental conditions and the 
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ability of myeloid cells isolated from regenerating muscles to produce superoxide, 
sorted macrophages and neutrophils were immediately treated with PMA, which 
induces an oxidative burst and is widely used to study ROS production in myeloid 
cells. In this condition, PMA-stimulated neutrophils significantly produced ROS, with 
an upregulation of superoxide release of 162.6±9.4% (p<0.001) (Figure 2A, right 
panel).  
Additionally, a skeletal muscle injury model with concomitant bacterial contamination 
with LPS was used to induce a stronger pro-inflammatory profile of Ly6Cpos 
macrophages (Varga et al., 2016) (Figure 2B, left panel). No significant superoxide 
production was detected in both macrophage subsets and neutrophils, as compared 
with the control solution (Figure 2B, right panel). Again, treatment with PMA 
stimulated only neutrophils to produce superoxide (144.1±13.2%, p<0.05) (Figure 
2B, right panel). Taken together, these results indicate that after an injury, 
macrophages invading skeletal muscle release, if any, very low levels of superoxide. 
 
Gene expression profiling does not reveal antioxidant-related response in 
macrophages after skeletal muscle injury 
The oxidative stress signature of macrophages present in regenerating muscles was 
investigated, using a microarray analysis published in (Varga et al., 2016). As 
expected, Ly6Cpos macrophages expressed higher levels of a series of genes known 
to be associated with pro-inflammatory macrophages in skeletal muscle 
regeneration, including selectin L, CSF1, IL6 and CCR1 (Figure 3, upper panel). A 
set of antioxidant genes that would identify an antioxidant-related transcriptional 
signature was analyzed in both macrophage subsets. There was no significant 
differential expression of 30 genes associated with response to oxidative stress 
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between inflammatory Ly6Cpos and restorative Ly6Cneg macrophage subsets (Figure 
3, lower panel).  
 
NAC treatment impairs skeletal muscle regeneration after injury  
To further assess a potential functional role of ROS in macrophages during skeletal 
muscle regeneration, we used a pharmacological approach using antioxidant NAC 
oral treatment, given from the time of muscle injury. Indeed, NAC should counteract 
the ROS released at early time points by pro-inflammatory macrophages. Inversely, if 
no ROS are present in the injured muscle, NAC should not affect skeletal muscle 
regeneration.  
First, macrophage inflammatory status was investigated by performing double 
immunofluorescent staining for F4/80 and iNOS or CD206, to identify pro- and anti-
inflammatory macrophages, respectively (Mounier et al., 2013). At day 4 after injury, 
there was no difference in the percentage of macrophages expressing iNOS or 
CD206 between control and NAC-treated muscles (Figure 4A). The number of 
necrotic and phagocyted myofibers was calculated 8 days after injury, a time point 
when most of necrosis and phagocytosis of injured myofibers is over (Mounier et al., 
2013). Although exhibiting high variations between individuals, NAC-treated group 
did not significantly differ from the control group (Figure 4B), indicating no significant 
difference in the time course of the regeneration process. Four weeks after injury, 
NAC treatment was associated with a reduction of body weight (-9%, p<0.01), 
Tibialis Anterior muscle mass (-15%, p<0.001) and Tibialis Anterior mass/body mass 
ratio (-8%, p<0.05) (Figure 5B). This was correlated with a decrease in mean Cross 
Section Area (-15%, p<0.05) and a shift of the myofiber size towards the smaller 
ones (Figure 5C). Additionally, muscles from NAC-treated group displayed a 
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significant lower number of nuclei per fiber as compared with the control group (-
22%, p<0.001) (Figure 5D). Finally, NAC-treated muscles did not show a significant 
difference in the number of satellite cells (Figure 5E). Altogether, these results 
suggest that NAC treatment primarily affected myofiber growth than early events 
related to inflammation during skeletal muscle regeneration.  
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DISCUSSION 
We investigated ROS release from macrophages during regenerating skeletal 
muscle and provided evidence that after a sterile injury, infiltrated macrophages did 
not release ROS and that antioxidant supplementation impaired long term skeletal 
muscle regeneration. To our knowledge, only one study investigated whole skeletal 
muscle redox changes following skeletal muscle injury induced by venom injection. It 
was described that skeletal muscle injury is accompanied by an increase of ROS 
production within the whole tissue from 1 to 7 days after injury (Vezzoli et al., 2011). 
However, the pro/antioxidant-related measurements were not specific to macrophage 
populations. These results, combined to those of the present study, suggest that 
ROS present in the early injured muscle are mainly derived from the myofiber than 
from the inflammatory compartment. 
ROS are short lived and direct detection is difficult, notably in vivo, despite recent 
technological advances (Murphy et al., 2011; Winterbourn, 2008). Here, we used 
biochemical assays such as ferricytochrome c reduction and Amplex Red 
technology, which are robust, specific and adequate methods to detect the major 
ROS that are superoxide and hydrogen peroxide produced by the cells and released 
in their microenvironment (Bernard et al., 2012; Wang et al., 2012).  
We report that among a set of in vitro activation, only macrophages treated with 
PMA, which induces the oxidative burst in macrophages (Abbas et al., 2014), present 
a significant ROS production. Additionally, no difference was observed in the release 
of H2O2, which is the product of superoxide dismutation, between the different 
activated macrophage populations. Protein expression of MnSOD, responsible of the 
dismutation of superoxide into hydrogen peroxide, the most common reaction of ROS 
metabolism cascade at this step (Holmstrom and Finkel, 2014), is higher in IFN 
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treated macrophages as compared with other activated macrophages. This distinct 
pattern of MnSOD is a hallmark of IFN-activated macrophages (Lawrence and 
Natoli, 2011). This result indicates that a higher MnSOD protein expression may 
counteract a higher production of superoxide (not detectable in our experimental 
conditions) as a stress response to restore cellular homeostasis.  
Ex vivo isolation of pure populations of pro-inflammatory and anti-inflammatory 
macrophages (Ly6Cpos and Ly6Cneg, respectively) two days after muscle injury 
revealed no significant superoxide release by these cells. Technically, sorted cells, 
here neutrophils, were shown to secrete superoxide after PMA treatment. Similar 
results were observed after muscle injury upon LPS co-injection, that induces a 
stronger pro-inflammatory profile in Ly6Cpos macrophages (Varga et al., 2016). ROS 
production is an important feature of macrophages, notably following activation with 
pathogens (Fang, 2004; Laskin et al., 2011; West et al., 2011), that constitutes a 
different context from sterile tissue injury. The absence of a high oxidative response 
in macrophages upon muscle injury, notably in Ly6Cpos macrophages at early time 
points after injury, was confirmed by gene expression analysis. The mRNA 
expression of about 30 genes related to oxidative stress did not differ between 
inflammatory Ly6Cpos and restorative/Ly6Cneg macrophage from injured muscle. More 
broadly, gene profiling analysis of these two populations indicated that following a 
sterile muscle injury, inflammatory Ly6Cpos macrophages exhibit a specific 
inflammatory profile which is different from the classical M1 (IFN driven) status and 
which is strongly different from that of pathogen-challenged macrophages (Varga et 
al., 2016).  
Finally, our in vivo pharmacological approach aimed at targeting ROS production 
early after injury, with the antioxidant NAC, a molecule commonly used as 
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therapeutics in a large number of pathophysiological contexts including skeletal 
muscle diseases and in exercise and sport performance context (Le Moal et al., 
2017; Michailidis et al., 2013). We showed that NAC treatment did not alter 
macrophage phenotype at early time points after injury, in accordance with the above 
results indicating the absence or ROS release from macrophages in this context. 
While the number of necrotic myofibers was not significantly different from that 
observed in the control muscle, NAC-treated muscles showed a highly heteregenous, 
somewhat increased level of necrosis 8 days after the injury, deserving further 
investigation on the phagocytic capacities of macrophages in these conditions. 
Finally, parameters of myofiber growth and fusion were altered in NAC-treated 
muscle 28 days after injury, suggesting and impact of anti-oxidant treatment on ROS-
unrelated properties of restorative macrophages or directly on the myogenesis 
process. However, the number of satellite cells was unchanged after NAC treatment, 
suggestive of an impact of NAC on the late stage of myogenesis, that deserves 
further exploration. Indeed, several pathways involved in myogenesis processes may 
be regulated by oxidative stress, for instance IGF-I signaling or Akt-mTOR pathways 
(Le Moal et al., 2017). This is also suggested by a study showing that NAC 
supplementation after an exercise-induced muscle damage (EIMD) in human blunts 
the circulating inflammatory response (assessed by indirect measurements in blood) 
and decreases the EIMD-induced increase in the phosphorylation of a series or 
proteins involved in myofiber growth (PKB, mTOR, p70S6K, S6, MAPK P38). 
Consequently, performance of the NAC-treated group was decreased (Michailidis et 
al., 2013). 
Our results appear to be in sharp contrast with what is observed during muscular 
dystrophies. Indeed, the increase in oxidative stress in muscular dystrophies is a 
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well-known process and correlates with the severity of the pathology (Le Moal et al., 
2017). Accordingly, anti-oxidant treatments ameliorate the morphological, 
biochemical, and functional phenotype of the diseased muscle, including a decrease 
in inflammatory cells (Le Moal et al., 2017). However, the redox status of 
inflammatory cells, including macrophages, has not been addressed in this 
pathological context yet. Nevertheless, as the inflammatory status of macrophages is 
different during skeletal muscle regeneration and during dystrophies (Lemos et al., 
2015; Vidal et al., 2008), it is likely that their redox status will also differ significantly 
between acute and chronic injuries. 
In conclusion, this study indicates that, contrary to an immune challenge implicating 
bacteria or virus, macrophage-derived ROS release is absent or weak after a sterile 
tissue damage, and does not impact the skeletal muscle regeneration process. 
Additionally, we report that antioxidant supplementation from the time of injury does 
not impact macrophage inflammatory status but may conversely be deleterious in the 
later restorative phase of skeletal muscle regeneration. 
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FIGURES LEGENDS 
Figure 1. ROS and antioxidant measurements in activated macrophages in 
vitro. 
BM-derived macrophages were activated in vitro using different effectors. (A) 
Detection of superoxide in conditioned medium was performed after 1h of incubation 
with ferricytochrome c solution using spectrophotometry (Optical Density, O.D.). (B) 
Detection of hydrogen peroxide was performed on conditioned medium with the 
Amplex Red hydrogen peroxide/peroxidase assay kit. (C) Mitochondrial MnSOD 
(SOD2) expression by western-blotting. Panel illustrates a representative gel. (D) 
Cytosolic Cu-ZnSOD (SOD1) expression by western-blotting. Panel illustrates a 
representative gel. Results are mean +/-SEM. A minimum of 3 independent 
experiments were performed. *p<0.05 different from untreated (NT) macrophages (A) 
or IL-10 activated macrophages (C). 
 
Figure 2. Superoxide detection in conditioned medium of macrophages sorted 
from injured skeletal muscle.  
 Ly6Cpos and Ly6Cneg macrophages were sorted from regenerating Tibialis Anterior 
muscles 2 days after injury with cardiotoxin (A) and with cardiotoxin + LPS (B). On 
the left, flow cytometry dot plots illustrate a representative experiment showing the 3 
sorted populations as neutrophils (black dotted line circle), Ly6Cpos inflammatory 
macrophages (black plain circle) and Ly6Cneg restorative macrophages (plain gray 
circle). On the right, detection of superoxide in conditioned medium was performed 
after 1h of incubation with ferricytochrome c solution using spectrophotometry. When 
indicated PMA treatment (50 ng/ml) was applied for 60 min. Results are expressed 
as a percentage of the quantity of superoxide detected in the condition medium of 
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control solution (ferricytochrome c solution, without cells). A minimum of 3 
independent experiments were performed. **p<0.01, ***p<0,001 different from 
control. 
 
Figure 3. Gene expression profiling of oxidative stress-associated network in 
macrophages sorted from injured skeletal muscle. 
Two days after injury, Ly6Cpos and Ly6Cneg macrophages were sorted from 
regenerating muscle and processed for microarray as in (Varga et al., 2016). Upper 
panel: heatmap of genes referred as highly expressed in Ly6Cpos macrophage 
subset. Lower panel: heatmap of 30 genes associated with oxidative stress. Results 
represent the mean of 3 independent experiments.  
 
Figure 4: NAC supplementation effect on early steps of muscle regeneration: 
impact on macrophages.  
Tibialis Anterior muscle was injured and mice were treated or not with NAC for 8 
days. (A) Upper panel: Immunofluorescent staining for F4/80 and iNOS or CD206 on 
regenerating muscle 4 days after injury in control and NAC-treated mice. Arrow 
represents double-positive cells and arrowheads represent macrophages negative 
for the inflammatory marker. Bar=50 μm. Lower panel: quantification of the number of 
iNOSpos and CD206pos macrophages. (B) Necrotic/phagocytosed fibers were counted 
on muscle sections stained with H/E at day 8 after injury. Results are mean+/-SEM of 
a minimum 3 mice.  
 
Figure 5. NAC supplementation effect on late steps of muscle regeneration: 
impact on myogenesis. 
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Tibialis Anterior muscle was injured and mice were treated or not with NAC for 8 
days. Muscles were analyzed at day 28. (A) Hematoxylin/Eosin staining of Tibialis 
Anterior muscle sections of control mice. Bar=50 μm. (B) Total body weight, Tibialis 
Anterior mass and body mass/ Tibialis Anterior muscle/body mass ratio. (C) Mean 
and distribution of Cross Section Areas. (D) Number of nuclei per myofiber in 
regenerating muscle. (E) Number of Pax7+ cells per 100 fibers in regenerating 
muscle. Results are mean +/- SEM of a minimum 3 mice. *p<0.05, **p<0.01, 
***p<0.001 different from control. 
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